Literature DB >> 33488424

Blunted Expansion of Regulatory T Lymphocytes Is Associated With Increased Bacterial Translocation in Patients With Major Depressive Disorder.

Miguel Angel Alvarez-Mon1,2,3, Ana Maria Gomez-Lahoz2, Arantxa Orozco4, Guillermo Lahera2,4,5, M Dolores Sosa-Reina2, David Diaz2, Agustin Albillos2,6,7,8, Javier Quintero3,9, Patricio Molero1, Jorge Monserrat2, Melchor Alvarez-Mon2,7,8,10.   

Abstract

Background: Major Depressive Disorder (MDD) is associated with both proinflammatory and adaptive immune response abnormalities. Regulatory T lymphocytes (Tregs), a subtype of CD4+ T cells, are relevant for maintaining immune-inflammatory system homeostasis and control of inflammation such as the kind potentially induced by the interactions between the intestinal microbiome and gut mucosa. We investigated the Treg population and its distribution along their stages of differentiation/activation, as well as its function in MDD patients without concomitant diseases. We also studied the potential association between Treg alterations, intestinal barrier damage, and bacterial translocation.
Methods: 30 MDD patients and 20 healthy controls were studied. The levels of circulating CD25FoxP3+ Tregs and their distribution on the naïve (TN), effector (TE), central (TCM), and effector memory(TEM) differentiation/activation stages were analyzed using polychromatic flow cytometry. Chemokine receptors (CCR) 2, 5, and 6, and the intracytoplasmic IL-10 expression by the Tregs were also analyzed. The serum IL-10 was measured using Luminex. The serum levels of zonulin and the intestinal fatty acid-binding protein (I-FABP), both markers of gut barrier function, and the LPS-binding protein (LBP), a marker of bacterial translocation, were measured using an enzyme-linked immunosorbent assay.
Results: MDD patients had increased number of circulating Tregs cells with enhanced number of Tregs at the TN, TE, TCM, and TEM stages. The percentage of Tregs cells at TN stage was significantly higher in MDD patients. The percentage of Tregs that expressed CCR2 and CCR6 was increased as well as those expressing IL-10. MDD patients had significantly increased levels of circulating I-FABP and LBP. MDD patients with high LBP levels had a significant reduction in the number of circulating Tregs compared to normal-LBP MDD patients. Conclusions: MDD patients showed an expansion of circulating Tregs and their CD25highFoxP3+ and CD25lowFoxP3+ subsets throughout the different stages of CD4+ T lymphocyte differentiation/activation. Tregs also showed an increased frequency of cells expressing CCR6 and CCR2. IL-10 Treg production was also enhanced in MDD patients that concurrently had increased serum IL-10 levels. However, this Treg expansion was blunted in MDD patients with gut barrier damage and increased bacterial translocation.
Copyright © 2021 Alvarez-Mon, Gomez-Lahoz, Orozco, Lahera, Sosa-Reina, Diaz, Albillos, Quintero, Molero, Monserrat and Alvarez-Mon.

Entities:  

Keywords:  CD4+ lymphocytes; LPS-binding protein; chemorreceptors; gut barrier; interleukin 10 (IL10); major depressive disorder; regulatory T lymphocytes (Treg)

Year:  2021        PMID: 33488424      PMCID: PMC7820111          DOI: 10.3389/fpsyt.2020.591962

Source DB:  PubMed          Journal:  Front Psychiatry        ISSN: 1664-0640            Impact factor:   4.157


  58 in total

Review 1.  Th17 cells in depression.

Authors:  Eléonore Beurel; Jeffrey A Lowell
Journal:  Brain Behav Immun       Date:  2017-08-03       Impact factor: 7.217

Review 2.  Depression.

Authors:  Gin S Malhi; J John Mann
Journal:  Lancet       Date:  2018-11-02       Impact factor: 79.321

3.  Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer's patches.

Authors:  Masayuki Tsuji; Noriko Komatsu; Shimpei Kawamoto; Keiichiro Suzuki; Osami Kanagawa; Tasuku Honjo; Shohei Hori; Sidonia Fagarasan
Journal:  Science       Date:  2009-03-13       Impact factor: 47.728

4.  Emerging tendency towards autoimmune process in major depressive patients: a novel insight from Th17 cells.

Authors:  Yili Chen; Tang Jiang; Peisong Chen; Juan Ouyang; Guiyun Xu; Zhijie Zeng; Yanhong Sun
Journal:  Psychiatry Res       Date:  2010-12-03       Impact factor: 3.222

Review 5.  Phenotypical and functional specialization of FOXP3+ regulatory T cells.

Authors:  Daniel J Campbell; Meghan A Koch
Journal:  Nat Rev Immunol       Date:  2011-02       Impact factor: 53.106

Review 6.  Epidemiology of depression and diabetes: a systematic review.

Authors:  Tapash Roy; Cathy E Lloyd
Journal:  J Affect Disord       Date:  2012-10       Impact factor: 4.839

Review 7.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

8.  Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement.

Authors:  Agustín Albillos; Antonio de la Hera; Mónica González; Jose-Luis Moya; Jose-Luis Calleja; Jorge Monserrat; Luis Ruiz-del-Arbol; Melchor Alvarez-Mon
Journal:  Hepatology       Date:  2003-01       Impact factor: 17.425

9.  Leaky gut biomarkers in depression and suicidal behavior.

Authors:  L Ohlsson; A Gustafsson; E Lavant; K Suneson; L Brundin; Å Westrin; L Ljunggren; D Lindqvist
Journal:  Acta Psychiatr Scand       Date:  2018-11-01       Impact factor: 6.392

Review 10.  Tissue regulatory T cells.

Authors:  Prudence PokWai Lui; Inchul Cho; Niwa Ali
Journal:  Immunology       Date:  2020-06-24       Impact factor: 7.397

View more
  9 in total

Review 1.  Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review.

Authors:  Javier Quintero; José R Gutiérrez-Casares; Cecilio Álamo
Journal:  Neurol Ther       Date:  2022-08-11

2.  "Leaky Gut" as a Keystone of the Connection between Depression and Obstructive Sleep Apnea Syndrome? A Rationale and Study Design.

Authors:  Oliwia Gawlik-Kotelnicka; Aleksandra Margulska; Agata Gabryelska; Marcin Sochal; Piotr Białasiewicz; Dominik Strzelecki
Journal:  Metabolites       Date:  2022-02-06

3.  Differential malondialdehyde (MDA) detection in plasma samples of patients with major depressive disorder (MDD): A potential biomarker.

Authors:  Miguel A Alvarez-Mon; Miguel A Ortega; Cielo García-Montero; Oscar Fraile-Martinez; Guillermo Lahera; Jorge Monserrat; Ana M Gomez-Lahoz; Patricio Molero; Luis Gutierrez-Rojas; Roberto Rodriguez-Jimenez; Javier Quintero; Melchor Alvarez-Mon
Journal:  J Int Med Res       Date:  2022-05       Impact factor: 1.573

Review 4.  The Problem of Malnutrition Associated with Major Depressive Disorder from a Sex-Gender Perspective.

Authors:  Cielo García-Montero; Miguel A Ortega; Miguel Angel Alvarez-Mon; Oscar Fraile-Martinez; Adoración Romero-Bazán; Guillermo Lahera; José Manuel Montes-Rodríguez; Rosa M Molina-Ruiz; Fernando Mora; Roberto Rodriguez-Jimenez; Javier Quintero; Melchor Álvarez-Mon
Journal:  Nutrients       Date:  2022-03-06       Impact factor: 5.717

Review 5.  Depression and Autoimmune Hypothyroidism-Their Relationship and the Effects of Treating Psychiatric and Thyroid Disorders on Changes in Clinical and Biochemical Parameters Including BDNF and Other Cytokines-A Systematic Review.

Authors:  Zofia Kotkowska; Dominik Strzelecki
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-24

Review 6.  Biological Role of Nutrients, Food and Dietary Patterns in the Prevention and Clinical Management of Major Depressive Disorder.

Authors:  Miguel A Ortega; Óscar Fraile-Martínez; Cielo García-Montero; Miguel Angel Alvarez-Mon; Guillermo Lahera; Jorge Monserrat; Maria Llavero-Valero; Luis Gutiérrez-Rojas; Rosa Molina; Roberto Rodríguez-Jimenez; Javier Quintero; Melchor Alvarez De Mon
Journal:  Nutrients       Date:  2022-07-28       Impact factor: 6.706

Review 7.  Understanding the basis of major depressive disorder in oncological patients: Biological links, clinical management, challenges, and lifestyle medicine.

Authors:  Oscar Fraile-Martinez; Miguel A Alvarez-Mon; Cielo Garcia-Montero; Leonel Pekarek; Luis G Guijarro; Guillermo Lahera; Miguel A Saez; Jorge Monserrat; Domitila Motogo; Javier Quintero; Melchor Alvarez-Mon; Miguel A Ortega
Journal:  Front Oncol       Date:  2022-09-16       Impact factor: 5.738

8.  Expansion of CD4 T Lymphocytes Expressing Interleukin 17 and Tumor Necrosis Factor in Patients with Major Depressive Disorder.

Authors:  Miguel Angel Alvarez-Mon; Ana Maria Gómez-Lahoz; Arancha Orozco; Guillermo Lahera; David Diaz; Miguel A Ortega; Agustin Albillos; Javier Quintero; Enrique Aubá; Jorge Monserrat; Melchor Alvarez-Mon
Journal:  J Pers Med       Date:  2021-03-19

Review 9.  Gut Microbiota Metabolites in Major Depressive Disorder-Deep Insights into Their Pathophysiological Role and Potential Translational Applications.

Authors:  Miguel A Ortega; Miguel Angel Alvarez-Mon; Cielo García-Montero; Oscar Fraile-Martinez; Luis G Guijarro; Guillermo Lahera; Jorge Monserrat; Paula Valls; Fernando Mora; Roberto Rodríguez-Jiménez; Javier Quintero; Melchor Álvarez-Mon
Journal:  Metabolites       Date:  2022-01-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.